Related Experiment Video
Updated: May 10, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Very low-dose lenalidomide therapy for elderly multiple myeloma patients
Kentaro Minagawa1, Hiroki Kawano, Takuma Suzuki
1Hematology, Department of Medicine, Kobe University Graduate School of Medicine.
Summary
Very low-dose lenalidomide (5 mg daily) shows promise for treating elderly patients with relapsed or refractory multiple myeloma. This approach may offer a safe and effective outpatient treatment option with manageable side effects.
Area of Science:
- Oncology
- Hematology
Background:
- Multiple myeloma treatment in elderly patients presents challenges, particularly managing adverse effects of lenalidomide.
- Dose reduction of lenalidomide is sometimes considered for older individuals.
Purpose of the Study:
- To evaluate the feasibility and efficacy of very low-dose lenalidomide in elderly patients with refractory or relapsed multiple myeloma.
- To assess the safety profile and adverse events associated with this reduced dosage regimen.
Main Methods:
- Retrospective analysis of 6 elderly patients (age >70 years) treated with very low-dose lenalidomide (5 mg daily).
- Monitoring treatment response and adverse events, including infections and hematological toxicities.
Main Results:
- Four out of six patients achieved a partial response or better.
- A median follow-up of 8.6 months showed comparable efficacy to previous findings.
- The primary adverse event was infection, mainly in early cycles; grade 3/4 hematological toxicities were notably absent.
Conclusions:
- Very low-dose lenalidomide (5 mg daily) appears to be a safe and effective option for selected elderly patients with multiple myeloma.
- Further investigation in prospective trials is warranted to confirm these findings.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...